Skip to main content
Sign In

University of Colorado Cancer Center

University of Colorado Cancer Center, A National Cancer Institute-designated Comprehensive Cancer Center

Updates and Reminders

Medical Quality Assurance Committee: Approved Program Changes 

  • Adenomas with High Grade Dysplasia (HGD) and Carcinoma in Situ (CIS) will both be considered non-invasive cancer. As follow-up for CIS or HGD is usually a repeat endoscopic procedure, patients with HGD or CIS will not be eligible for treatment funds. Follow-up exams will be covered by the Program.
  • Screening Guidelines: Increased Risk-FDR with history of adenoma are no longer considered to be at ‘increased risk’ unless the adenoma is ‘advanced’ (defined as >/= 1 cm in size and/or villous or tubulovillous histology). Advanced adenoma must be documented (i.e.​ colonoscopy report or other documentation from medical record from FDR must be reviewed by PN/clinic staff.)
  • Removal of Rectal Condylomas found during colorectal cancer screening in the Program will be covered by the Program, and will be tracked separately.
  • Treatment for carcinoid tumors of the colon found during colorectal cancer screening is covered by the Program.
  • CT colonography (virtual colonoscopy) will be covered by the Program for patients unable to complete a colonoscopy. 


Revision (5/19/14) CCSP Reimbursable Screening Guidelines​​ 

*​Please see Program Manual for complete screening guidelines*

Pogram Manual: Chapter 2.pdf

    • Average risk individuals' age to stop screening is 85 years.  ​
      Note:  Comorbidity should be considered for those between 75-85 years.
  • Increased risk individuals, 45 years and older, with blood in the stool or a positive FOBT are eligible for endoscopic evaluation through CCSP (colonoscopy).
  • Increased risk individuals, on a previous endoscopic screening, with sessile serrated polyp without dysplasia, at the initial time of polyp diagnosis, cololonsocopy every 5 years after initial polyp removal.  If then that exam is normal, colonoscopy every 5-10 years thereafter.
  • Increased risk individiuals, on a previous endoscopic screening, with any sessile serrated polyp with cytologic dysplasia, at the initial time of polyp diagnosis, colonoscopy every 3 years [providing that piecemeal removal has not been done and the adenoma(s) are completely removed].  If the follow-up exam is normal or shows only one or two small tubular adenomas with low-grade dysplasia, then colonoscopy every 5 years thereafter.​


FY15 Screening Deadlines and Check Ins.pdf- Fiscal Year 15: July 2014-June 2015- 

NCCRT 80% by 2018: The Colorado Colorectal Screening Program, along with several other organizations, have joined with the National Colorectal Cancer Roundtable to ensure that we reach the goal of getting 80% of eligible individuals screened for colorectal cancer by 2018.  Please click the link below for further information.

Visit Website


Thank you for your hard work and all of your efforts in increasing colorectal cancer screening rates across the state of Colorado!


© The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.